ELLANSÉ™ S

Ellanse S (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

A treatment takes approximately 30 minutes, depending on the area treated.
Ellanse S helps to bring back natural-looking beauty through immediate restoration of volume and stimulation of the body’s natural collagen production. By rebuilding and rejuvenating, layer by layer, Ellansé creates a firm foundation for lasting results. With its unique formulation that stimulates your body’s collagen to brighten your skin and improve its volume, firmness, and elasticity, it provides short-term and long-term benefits to the skin.

• UPPER-FACE
  • Forehead
  • Temples
  • Brow area
• MID-FACE
  • Nose reshaping
  • Cheek augmentation
  • Nasolabial lines (the lines from your nose to the corners of your mouth)
• LOWER-FACE
  • Corners of the mouth
  • Marionette lines (the vertical lines that run down from the corners of your mouth)
  • Chin
  • Jawline

SMOOTHER, MORE SPHERICAL MICROSPHERES. Ellansé S is composed of smooth, spherical PCL particles with a diameter of 25-50μm. Since rough surfaces and irregular-shaped particles can cause adverse reactions (such as nodules and decreased collagen deposition), it’s been specifically designed for optimum compatibility with the body.

IMMEDIATE AND SUSTAINED PERFORMANCE

• Collagen stimulation induces long-term volumizing capacity, for lasting, natural-looking results from a minimum of 18 months
• Immediate results compared to Poly-L-Lactic Acid (PLLA)-based filler.
• Improved stability and duration compared to Calcium Hydroxylapatite (CaHA)-based filler.

The only differentiator between Ellanse S and Ellansé M is the initial polymer chain length of the PCL.

Based on the area chosen, Cannula or direct needle approach is the best. It depends on the preference of the practitioner and the area of treatment. It is best to avoid using Ellansé in combination with or anywhere else where facial rejuvenation was previously done. It is also best not to use Ellansé closer to sites where other products have been used.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type, there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, edema, erythema, lumps/nodules, etc.), pain (which may be temporary or persistent in nature), transient hematoma or bruising.

OTHER POTENTIAL ADVERSE EVENTS INCLUDE:

• Injection-related reactions, include itching, discoloration, or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.
• As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, hematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, edema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at the implant site which may result in induration and/or scar formation.
• Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia, and neurological complications.

Contraindications

• In combination with facial peelings, laser, or ultrasound-based treatments.
• If the patient has cutaneous disorders, inflammation, or an infection at or near the treatment site.
• Patients with known hypersensitivity to lidocaine and/or amide local anesthetic agents, to hyaluronic acid with a history of severe allergy or anaphylactic shock.
• Patients with autoimmune diseases.
• Patients with nickel allergy.
• Patients under medical prescription.
• In pregnant or breastfeeding mothers and in children.
• To be avoided in combination with other fillers.

Aftercare

Minimize exposure of the treated area to sun or UV radiation, as well as to extreme cold temperatures. In case of any redness or swelling that persists beyond 48 hours (about 2 days), please consult with the practitioner.